Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Frilabiol Immune Defense
- Development stage
- Unknown
- Lead developer
- FRiLAB
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Frilabiol Immune Defense is an oral phytotherapeutic food supplement developed and marketed by the Swiss company FRiLAB Laboratories. Formulated as a capsule for once-daily administration, the product is designed to strengthen the body's natural immune defenses. It utilizes an innovative dosage form intended to provide both rapid action and a prolonged therapeutic effect. As a plant-based supplement, it is positioned within FRiLAB's line of health products rather than as a regulated pharmaceutical drug, and it is specifically indicated for adult use, excluding pregnant or breastfeeding women.
- Brand names
- Frilabiol Immune Defense
Beyond the preview
Go deeper on Frilabiol Immune Defense.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Frilabiol Immune Defense.